Cargando…
Assessing Patient Satisfaction Following Sodium Glucose Co-Transporter 2 Inhibitor Treatment for Type 1 Diabetes Mellitus: A Prospective Study in Japan
INTRODUCTION: In Japan, several sodium glucose co-transporter 2 (SGLT2) inhibitors have been used for type 1 diabetes mellitus as an adjuvant therapy to insulin therapy; however, there are no clinical reports regarding the satisfaction of its use. Therefore, we conducted a survey among patients with...
Autores principales: | Ishibashi, Ryoichi, Baba, Yusuke, Kakinuma, Kyoka, Takasaki, Atsushi, Hiraga, Chihiro, Harama, Tomomi, Yamamoto, Tetsuya, Nakamura, Susumu, Koshizaka, Masaya, Maezawa, Yoshiro, Uchida, Daigaku, Okajima, Fumitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843726/ https://www.ncbi.nlm.nih.gov/pubmed/33237553 http://dx.doi.org/10.1007/s13300-020-00971-2 |
Ejemplares similares
-
Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities: Single-Arm, Exploratory Trial
por: Baba, Yusuke, et al.
Publicado: (2021) -
Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema
por: Takatsuna, Yoko, et al.
Publicado: (2020) -
Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with Diabetes mellitus
por: Tatsumi, Tomoaki, et al.
Publicado: (2022) -
Imeglimin‐mediated glycemic control in maternally inherited deafness and diabetes
por: Ishibashi, Ryoichi, et al.
Publicado: (2023) -
Lifetime extension and the recent cause of death in Werner syndrome: a retrospective study from 2011 to 2020
por: Kato, Hisaya, et al.
Publicado: (2022)